Volver al buscador
FDAFDA · Alimentos y medicamentos·N.º oficial Z-1031-2013

Medtronic Prostiva RF Therapy Generator. The Prostiva RF system is indicated for the treatment of symptoms due to urinary outflow obstruction secondary to benign prostatic hyperplasia (BPH) in men over the age of 50 with prostate sizes between 20 and 50 cm3.

Publicado el 10 de abril de 2013 · Inicio del retiro: 27 de febrero de 2013

Resumen

FDA registra el retiro Z-1031-2013 de dispositivos médicos de Clase II, publicado el 10 de abril de 2013 e iniciado el 27 de febrero de 2013. Empresa responsable: Medtronic Neuromodulation; Estado: Finalizado; Cantidad reportada: 848 (696 US, 152 OUS); Lote: all Model 8930 radio frequency (RF) generators are affected. La Clase II indica posibles consecuencias temporales o médicamente reversibles, o una probabilidad remota de consecuencias graves.

Estado reportado al momento de publicación: Terminated — openFDA actualiza semanalmente y este campo no refleja el estado más reciente. Confirma siempre con la fuente oficial.

Qué peligro representa

Medtronic has found through device testing that if the optional footswitch is not connected to the Model 8930 RF generator during use, an electrostatic discharge (i.e. static electricity) to the footswitch connector port may toggle the RF output on or off. If this were to occur, it could result in unintentionally starting or stopping the lesion process, depending on the current status of the equi

Qué hacer

Voluntary: Firm initiated · Letter

Recibe un correo cuando FDA publique un retiro como este

Gratis. Solo te escribimos cuando hay un retiro nuevo que coincide. Te das de baja con un clic.

Detalles del retiro

Fabricante
Medtronic Neuromodulation
Distribuidor
Nationwide Distribution including Puerto Rico and all States in continental USA except ID, MT, and NH.
Lote
all Model 8930 radio frequency (RF) generators are affected
Clasificación de riesgo
Class II
Área (FDA)
device
País
United States

Retiros relacionados

Preguntas sobre este retiro

¿Medtronic Prostiva RF Therapy Generator. The Prostiva RF system is indicated for the treatment of symptoms due to urinary outflow obstruction secondary to benign prostatic hyperplasia (BPH) in men over the age of 50 with prostate sizes between 20 and 50 cm3. fue retirado del mercado?

Sí. FDA publicó el retiro Z-1031-2013 el 10 de abril de 2013. Peligro reportado: Medtronic has found through device testing that if the optional footswitch is not connected to the Model 8930 RF generator during use, an electrostatic discharge (i.e. static electricity) to the footswitch connector port may toggle the RF output on or off. If this were to occur, it could result in unintentionally starting or stopping the lesion process, depending on the current status of the equi

¿Qué debo hacer si tengo este producto?

Voluntary: Firm initiated · Letter